AdvisorShares Pure US Cannabis ETFMSOS
MSOS
0
Funds holding %
of 7,312 funds
–
Analysts bullish %
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
26% more call options, than puts
Call options by funds: $7.06M | Put options by funds: $5.62M
5% less repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 41
7.81% less ownership
Funds ownership: 33.3% [Q4 2024] → 25.49% (-7.81%) [Q1 2025]
13% less funds holding
Funds holding: 175 [Q4 2024] → 153 (-22) [Q1 2025]
46% less capital invested
Capital invested by funds: $167M [Q4 2024] → $90.3M (-$76.5M) [Q1 2025]
58% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 33
80% less funds holding in top 10
Funds holding in top 10: 5 [Q4 2024] → 1 (-4) [Q1 2025]
Research analyst outlook
We haven’t received any recent analyst ratings for MSOS.
Financial journalist opinion
Based on 3 articles about MSOS published over the past 30 days
Negative
Seeking Alpha
1 week ago
MSOS: Headed For A New All-Time Low
MSOS has significantly underperformed the broader cannabis market, dropping 41.2% YTD versus a 27.8% sector decline. I downgraded MSOS to Strong Sell in April due to persistent risks, and the ETF has continued to fall since then. Key concerns include poor chart performance, plunging trading volume, high portfolio concentration, and waning investor interest in multi-state operators.
Negative
Seeking Alpha
2 weeks ago
MSOS ETF Underperforms Compared To Canadian Cannabis Peers
MSOS holds US cannabis MSOs exclusively. It allows for exposure to US cannabis companies. US MSO stocks are historically down.
Positive
Seeking Alpha
2 weeks ago
MJ And MSOS: Cannabis' Inevitable Legalization Offers High Upside Despite Blunt Risks
Cannabis legalization is inevitable, driven by shifting political, generational, and fiscal dynamics, especially as Republicans seek votes and tax revenue. Despite high risks, the upside for cannabis ETFs like MJ and MSOS is compelling, making them suitable for risk capital allocations. Demographic trends and bipartisan support suggest federal decriminalization is only a matter of time, further boosting the industry's long-term prospects.
Neutral
Benzinga
1 month ago
Hedge Fund Veteran Doug Kass Says Most Cannabis Stocks Are 'Walking Dead,' But These 4 Names Stand Out
Veteran hedge fund manager Doug Kass isn't mincing words about the state of the cannabis industry. In a recent column titled “Picking the Cannabis Winners in an Industry Full of the Walking Dead,” the Seabreeze Partners president outlined why he believes most public cannabis companies are distressed and structurally unsound — but also identified a small group he still considers investable.
Positive
See It Market
2 months ago
Cannabis Stocks Rally As Buzz Grows
There have been a lot of headlines about cannabis and marijuana lately. From the bipartisan support in government, to states looking to legalize at least for medical, to Mexico having a pro canna protest, the buzz leans towards a change in the law.
Neutral
Benzinga
2 months ago
Why Cannabis Stocks Jumped By Double Digits And Why Analysts Say 'Don't Drink The Kool-Aid In One Gulp'
Author's note: this article has been updated to include more context and commentary from analysts.
Negative
Seeking Alpha
2 months ago
Sell MSOS And Its 3 Largest Holdings
I am downgrading MSOS (and its top holdings to Strong Sell or Sell), to Strong Sell due to ongoing 280E taxation concerns and poor market performance. MSOS has seen significant redemptions since March and trading volume declines, with its shares outstanding increasing only 1.2% year-to-date amidst a 32.8% price drop. Despite low valuations, high debt levels and negative EPS projections for 2025 make Curaleaf and Trulieve risky investments.
Neutral
ETF Trends
2 months ago
Are These ETFs Cheap Yet? Crypto, Cannabis, Chips
When markets move, we can learn a lot from the outperformers. But we can also learn a lot from the underperformers — and maybe even find opportunities.
Positive
Market Watch
5 months ago
Cannabis stocks climb on RFK Jr. approval, Senate marijuana-banking hearing
Cannabis stocks tend to move on speculation around potential federal reforms around pot.
Neutral
Seeking Alpha
5 months ago
MSOS: High Risk/Reward On The Cannabis Market
The AdvisorShares Pure US Cannabis ETF offers a high-risk/high-reward opportunity, especially if cannabis is rescheduled to Schedule III in 2025. MSOS is an actively managed ETF focused on US cannabis companies, with potential growth as more states legalize cannabis. Federal legislative changes, particularly rescheduling cannabis, could significantly boost MSOS, but the ETF faces risks like redemptions and legislative setbacks.
Charts implemented using Lightweight Charts™